USING MINIMAL RESIDUAL DISEASE AS A SURVIVAL PREDICTOR FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Aashal Shah, 4209842

MULTIPLE MYELOMA IN A RESTRICTED-ACCESS HEALTHCARE SETTING: SURVIVAL OUTCOMES AND PROGNOSTIC RISK FACTORS

EHA Library, Francisca Ramirez Aspiazu, 4209843

PREDICTIVE VALUE OF HIGH-THROUGHPUT IN VITRO DRUG SENSITIVITY TESTING FOR THERAPEUTIC EFFICACY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Xi Zhang, 4209844

THE ROLE OF KINETICS OF HEMATOLOGIC RESPONSE IN MULTIPLE MYELOMA WITH OBVIOUS RENAL IMPAIRMENT

EHA Library, Aijun Liu, 4209845

EVOLVING OUTCOMES IN MULTIPLE MYELOMA: A 30-YEAR SINGLE CENTER REAL-WORLD EXPERIENCE.

EHA Library, Claudia Bellofiore, 4209846

EVALUATING THE CLINICAL BENEFIT OF ANTI-CD38 THERAPY IN MULTIPLE MYELOMA USING ESMO-MCBS:H AND ASCO-VF

EHA Library, Bushra Salman, 4209847

LISAFTOCLAX COMBINED WITH IXAZOMIB AND DEXAMETHASONE AFTER CART FOR MAINTENANCE THERAPY IN TRANSPLANT-INELIGIBLE RELAPSED/REFRACTORY HIGH-RISK MULTIPLE MYELOMA : TWO CASE REPORTS AND LITERATURE REVIEW

EHA Library, Shukai Qiao, 4209848

METABOLIC TUMOR BURDEN ON ¹⁸F-FDG PET/CT AS AN INDEPENDENT PROGNOSTIC MARKER IN MULTIPLE MYELOMA

EHA Library, Edibe Eker, 4209849

DEPRESSION AND ANXIETY FOLLOWING MULTIPLE MYELOMA:   A DANISH NATIONWIDE REGISTER-BASED COHORT STUDY

EHA Library, Klara Frederikke Koue Rydahl, 4209850

EFFICACY ANALYSIS OF SELINEXOR-BASED REGIMENS IN THE TREATMENT OF TRIPLE-CLASS REFRACTORY OR BEYOND MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE: A REAL-WORLD STUDY

EHA Library, Xin Li, 4209851

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF RELAPSED/REFRACTORY MULTIPLE MYELOMA IN CHINA: INSIGHTS FROM THE NICHE-MM REGISTRY (2018–2025)

EHA Library, Gang An, 4209852

PROGNOSTIC VALUE OF CIRCULATING PLASMA CELLS DETECTED BY FLOW CYTOMETRY VERSUS PERIPHERAL BLOOD SMEAR IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Li Bao, 4209854

ESA CO-ADMINISTRATION INDEPENDENTLY INCREASES THROMBOTIC RISK DURING LENALIDOMIDE THERAPY IN MULTIPLE MYELOMA: A REAL-WORLD COHORT STUDY

EHA Library, Anthony Naassan, 4209855

CLINICAL CHARACTERISTICS AND ADJUSTED IN-HOSPITAL OUTCOMES OF ACUTE PANCREATITIS IN PATIENTS WITH MULTIPLE MYELOMA: A NATIONWIDE ANALYSIS

EHA Library, Hala Soomro, 4209856

ULTRA-EARLY MORTALITY (≤90 DAYS) AND ITS PREDICTORS IN NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-BASED REGIMENS: AN AMBISPECTIVE REAL-WORLD STUDY FROM A RESOURCE-LIMITED LMIC SETTING

EHA Library, Rajat Goyal, 4209857

EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA IN A RESOURCE-LIMITED SETTING : ABOUT A SENEGALESE COHORT OF 99-PATIENTS

EHA Library, Nata Dieng, 4209858

REAL WORLD DATA ON INITIATION AND DOSE RAMP-UP OF TECLISTAMAB USING TOCILUZIMAB PROPHYLAXIS AND MANAGEMENT OF TOXICITIES IN A DISTRICT GENERAL HOSPITAL SETTING WITH NO PREVIOUS BISPECIFIC EXPERIENCE

EHA Library, eddy ukponahunsi, 4209860

SAFETY AND RELIABILITY OF ISATUXIMAB SUBCUTANEOUS ON-BODY INJECTOR: RESULTS ACROSS THE PHASE 3 IRAKLIA, PHASE 2 IZALCO AND PHASE 1B TCD15484 TRIALS

EHA Library, Xavier Leleu, 4209861

“ANTI-CD38–VRD QUADRUPLET REGIMENS IN GERIATRIC PATIENTS WITH MULTIPLE MYELOMA INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION: A REAL-WORLD STUDY OF FEASIBILITY AND SAFETY.”

EHA Library, Belkacem MANSOUR, 4209862

DARATUMUMAB-BASED THERAPY IN HIGH-RISK CYTOGENETIC MULTIPLE MYELOMA: A REAL-WORLD RETROSPECTIVE CYTOGENETIC SUBGROUP ANALYSIS

EHA Library, Bo Lu, 4209863

DARATUMUMAB-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: A SINGLE-CENTER REAL-WORLD STUDY OF DYNAMIC TRANSPLANT ELIGIBILITY, DEEP RESPONSE, AND PROGNOSIS IN THE 2025 IMS-IMWG ERA

EHA Library, Lijing Shen, 4209864

CLINICAL OBSERVATION OF POMALIDOMIDE COMBINED WITH DEXAMETHASONE IN THE TREATMENT OF POEMS SYNDROME UNSUITABLE FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Qike Zhang, 4209865

EVALUATION OF SAFETY AND EFFICACY OF DENOSUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN REAL LIFE: A SINGLE-CENTER EXPERIENCE

EHA Library, Alessandra Romano, 4209866

TRANSPLANT INELIGIBLE MULTIPLE MYELOMA A SYSTEMATIC REVIEW MEA-ANALYSIS COMPARING CYCLOPHOSPHAMIDE BORTEZOMIB DEXAMETHASONE AND DARATUMUMAB LENALIDOMIDE DEXAMETHASONE WITH FOCUS ON RENAL IMPAIRMENT

EHA Library, Mahmoud Meleha, 4209867

EFFICACY AND SURVIVAL OUTCOMES OF IXAZOMIB-BASED REGIMENS IN A REAL-WORLD CHINESE COHORT RE-STRATIFIED BY IMS/IMWG 2024 CRITERIA

EHA Library, Ning An, 4209868

STEADY-STATE HEMATOPOIETIC CELL MOBILIZATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING DARATUMUMAB-BASED  VERSUS NON DARATUMUMAB-BASED INDUCTION THERAPY: A REAL- WORLD EXPERIENCE

EHA Library, Xin Zhao, 4209869

COMPARATIVE OVERALL SURVIVAL OF IMMUNE EFFECTORS AND NOVEL TRIPLETS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A BAYESIAN NETWORK META-ANALYSIS

EHA Library, Shankar Biswas, 4209870

BASELINE AND DYNAMIC  EASIX  SCORE AS AN INDEPENDENT PREDICTOR OF MORTALITY FOR MULTIPLE MYELOMA IN THE LATIN AMERICAN CONTEXT: A FIRTH‑PENALIZED LOGISTIC REGRESSION ANALYSIS

EHA Library, Gledy Jimenez Tornero, 4209871

IMPACT OF THERAPEUTIC ADVANCES ON ATTRITION RATES IN MULTIPLE MYELOMA: A 30-YEAR SINGLE CENTER REAL-WORLD EXPERIENCE

EHA Library, Claudia Bellofiore, 4209872

CLINICAL CHARACTERISTICS, TREATMENT AND SURVIVAL OF PATIENTS WITH AL AMYLOIDOSIS IN MOSCOW

EHA Library, Ekaterina Zotina, 4209873

25 YEARS OF MULTIPLE MYELOMA CARE IN COLOMBIA. REAL-WORLD DATA FROM A MIDDLE-INCOME COUNTRY. ACHO'S RENEHOC REGISTRY REPORT

EHA Library, Kenny Mauricio Galvez Cardenas, 4209874

EFFICACY AND SAFETY OF APONERMIN COMBINED WITH POMALIDOMIDE-BASED REGIMENS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Xin Li, 4209875

EFFICACY AND SAFETY OF APONERMIN-SELINEXOR-DEXAMETHASONE (APO-SD) IN HEAVILY PRE-TREATED RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Chunrui Li, 4209876

CLINICAL FEATURES AND PROGNOSTIC FACTORS OF CARDIAC LIGHT CHAIN AMYLOIDOSIS: A SINGLE-CENTER STUDY OF 37 PATIENTS

EHA Library, Huawei Jiang, 4209877

UPDATED RESULTS OF ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR FOLLOW-UP OF A REAL-WORLD PROSPECTIVE STUDY

EHA Library, Jianhua You, 4209878

THE VALIDATION OF A MULTIPLE MYELOMA MINIMAL RESIDUAL DISEASE FLOW CYTOMETRY ASSAY FOR USE IN MULTI-CENTRIC CLINICAL TRIALS.

EHA Library, Eirini Kamileri, 4209879

HEALTH CARE PROFESSIONALS (HCPS) PERSPECTIVES ON TREATMENT AND MANAGEMENT OF LIGHT CHAIN (AL) AMYLOIDOSIS: AN INTERNATIONAL CROSS-SECTIONAL SURVEY STUDY

EHA Library, Jamie Zigterman, 4209880

DISTRIBUTION OF IGG SUBCLASSES AND THEIR ASSOCIATION WITH RISK STRATIFICATION IN IGG-ASSOCIATED PLASMA CELL DISORDERS: ANALYSIS OF 491 PATIENTS

EHA Library, Aileen Schenk, 4209881

ADDITION OF CARFILZOMIB TO DCEP (K-DCEP) IS A HIGHLY EFFECTIVE REGIMEN IN HEAVILY PRE-TREATED AND REFRACTORY MULTIPLE MYELOMA WITHOUT EXCESS TOXICITY

EHA Library, Shivem Shah, 4209882

APONERMIN COMBINED WITH THALIDOMIDE-DEXAMETHASONE (TD) OR TD PLUS OTHER AGENTS (TD+) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Chuanying Geng, 4209883

ALLG MM26-D1/AMN009 NOVEL COMBINATIONS FOR ORPHAN MYELOMA (NORM) PLATFORM STUDY

EHA Library, Georgia McCaughan, 4209884

RENAL RESPONSE OF PATIENTS WITH MULTIPLE MYELOMA WITH RENAL DYSFUNCTION TO DARATUMUMAB-BASED TREATMENT

EHA Library, Jiali Li, 4209885

DOES PELVIC BONE INVOLVEMENT DEFINE A DISTINCT PROGNOSTIC PHENOTYPE IN MULTIPLE MYELOMA? A RETROSPECTIVE SURVIVAL ANALYSIS

EHA Library, Ozlem Beyler, 4209886

REAL-WORLD ADHERENCE TO ANTI-PNEUMOCOCCAL VACCINATION GUIDELINES IN NEWLY TREATED MULTIPLE MYELOMA PATIENTS IN FRANCE: A NATIONWIDE PMSI ANALYSIS

EHA Library, Manon Sapet, 4209887

CLINICAL CHARACTERISTICS AND PROGNOSTIC ANALYSIS OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA

EHA Library, Jingliang Zhao, 4209888

EXAMINING THE ROLE OF NURSES IN MULTIPLE MYELOMA (MM) CARE: INSIGHTS FROM A EUROPEAN SURVEY

EHA Library, Maria Teresa San Miguel-Arregui, 4209889

DETERMINANTS OF 10-YEAR OVERALL SURVIVAL IN MULTIPLE MYELOMA: A MULTICENTER RETROSPECTIVE CASE-CONTROL STUDY IN THE CHINESE POPULATION

EHA Library, Yinyi Zhang, 4209890

DYNAMIC INFLAMMATORY HEMATOLOGIC MARKERS DURING INDUCTION THERAPY AND CLINICAL OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Alexandra-Ştefania Stroe-Ionescu, 4209891

SUSTAINING CONTEMPORARY NDMM CARE DURING WARTIME: EARLY OUTCOMES OF AN INTEGRATED ALL-UNDER-ONE-ROOF PATHWAY

EHA Library, Anna Sergeieva, 4209892

REAL-WORLD EFFICACY AND SAFETY OF CARFILZOMIB-BASED COMBINATION REGIMENS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, WEI CAI, 4209893

TECLISTAMAB INDUCED REMISSION IN REFRACTORY MONOCLONAL GAMMOPATHY ASSOCIATED COAGULATION DISORDERS

EHA Library, Johannes Thaler, 4209894

RISK ASSESSMENT IN NEWLY DIAGNOSED MYELOMA USING NGS, FISH, AND CONVENTIONAL CYTOGENETICS: A SINGLE-CENTER EXPERIENCE.

EHA Library, IŞIL ERDOĞAN ÖZÜNAL, 4209895

DECENTRALISING MYELOMA CARE; FEASIBILITY AND ADVANTAGES OF HOME-BASED BORTEZOMIB SELF-ADMINISTRATION FROM A REGIONAL PERSPECTIVE IN AUSTRALIA

EHA Library, Rohullah Sultani, 4209896

PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TECLISTAMAB COMBINED WITH DARATUMUMAB IN NEWLY DIAGNOSED MULTIPLE MYELOMA WITH CONCURRENT LIGHT CHAIN AMYLOIDOSIS, THE STAMINA TRIAL

EHA Library, Jing Li, 4209897

SHOULD COGNITIVE IMPAIRMENT BE AN EXCLUSION CRITERIA FOR TREATING MULTIPLE MYELOMA WITH BISPECIFIC ANTIBODIES? A UK TERTIARY CENTRE EXPERIENCE OF NEUROTOXICITY COMPLICATING TREATMENT

EHA Library, Sally Keat, 4209898

RISK STRATIFICATION, TREATMENT PATTERNS, AND SURVIVAL OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: A REAL-WORLD ANALYSIS FROM THE CHINESE MYELOMA COMMITTEE

EHA Library, Xuelin Dou, 4209899

INDUCTION STRATEGIES AND SURVIVAL IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA: A TUNISIAN 20-YEAR EXPERIENCE

EHA Library, Faten kallel, 4209900

PROGNOSTIC VALUE OF INTERPHASE FISH IN MULTIPLE MYELOMA: IMPLICATIONS FOR PRACTICE IN IRELAND BASED ON A SINGLE CENTER EXPERIENCE

EHA Library, Tushar Pramod, 4209901

SAFETY AND EFFICACY OF ISATUXIMAB IN NEWLY DIAGNOSED FRAIL PATIENTS OF MULTIPLE MYELOMA PATIENTS

EHA Library, Maher Salamoon, 4209902

CARDIOVASCULAR ADVERSE EVENTS IN NEWLY DIAGNOSED MULTIPLE MYELOMA: INCIDENCE, RISK FACTORS, AND PROGNOSTIC IMPACT

EHA Library, Dewan Zhao, 4209903

ANALYSIS OF MULTIPLE MYELOMA TREATMENT COSTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)

EHA Library, Catherine Moura, 4209904

TRANSITION TO IXAZOMIB-BASED MAINTENANCE FOLLOWING DARATUMUMAB-BASED INDUCTION FOR CONTINUOUS THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Ruijuan Li, 4209905

ADVANCING PERSONALIZED MANAGEMENT IN MULTIPLE MYELOMA: THE UNTAPPED VALUE OF MINIMAL RESIDUAL DISEASE-GUIDED TREATMENT

EHA Library, Anna Forsythe, 4209906

SECOND MALIGNANCIES IN MULTIPLE MYELOMA: A SINGLE-CENTER COHORT

EHA Library, Elifcan Aladag, 4209907

EVALUATING VARIATION IN THE MANAGEMENT OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) AMONG CANADIAN HEMATOLOGISTS: A QUALITY ASSURANCE STUDY

EHA Library, Christina Tam, 4209908

DELAYED DIAGNOSIS AND ADVANCED ORGAN INVOLVEMENT IN LIGHT-CHAIN AMYLOIDOSIS: INSIGHTS FROM A TERTIARY CARE CENTRE IN NORTHERN INDIA

EHA Library, NITIN GUPTA, 4209909

EXTRAMEDULLARY DISEASE VERSUS PARAMEDULLARY LESIONS IN NEWLY DIAGNOSED MULTIPLE MYELOMA: CLINICAL CHARACTERISTICS AND PROGNOSTIC IMPACT IN A SINGLE-CENTRE COHORT

EHA Library, Harberth Fernandez Leyva, 4209910

EFFICACY OF IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (IRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ≥3 PRIOR LINES OF THERAPY: A REAL-WORLD SINGLE-CENTER EXPERIENCE

EHA Library, Yuliia Makarets, 4209911

AUTOLOGOUS STEM CELL TRANSPLANTATION AS BRIDGING THERAPY PRIOR TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN MULTIPLE MYELOMA: A SINGLE-CENTRE EXPERIENCE

EHA Library, Ivanna Biochuk, 4209912

IMPACT OF AUTOLOGOUS STEM CELL TRANSPLANTATION ON OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Sviatlana Haurylava, 4209913

TRENDS IN FRONTLINE DARATUMUMAB USE OVER TIME AND DIFFERENCES IN UTILIZATION BY INSURANCE TYPE AMONG PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Anthony Corsi, 4209914

THE EMERGING ‘TRANSPLANT DEFERRED’ POPULATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) REPRESENTS A SUBSTANTIAL EVIDENCE GAP IN THE NOVEL-AGENT ERA

EHA Library, Shaji Kumar, 4209915

GAMMAGA: PROJECT FOR EDUCATION AND DIAGNOSIS OF GAUCHER DISEASE (GD) AND ACID SPHINGOMYELINASE DEFICIENCY (ASMD) IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE OR MULTIPLE MYELOMA

EHA Library, Alejandro Contento Gonzalo, 4209916

IMPEDE-VTE RISK STRATIFICATION AND REAL-WORLD THROMBOTIC PROPHYLAXIS IN MULTIPLE MYELOMA, NORTHERN MOROCCO

EHA Library, Siham Belkadi, 4209917

TREATMENT OF HIGH-RISK SMOLDERING MULTIPLE MYELOMA (HRSMM) WITH ISATUXIMAB, LENALIDOMIDE, ORAL CYCLOPHOSPHAMIDE AND DEXAMETHASONE: A SURVIVAL ADVANTAGE IN A CASE SERIES STUDY

EHA Library, Maher Salamoon, 4209918

IXAZOMIB- VERSUS BORTEZOMIB-BASED PROTEASOME INHIBITOR TRIPLET REGIMENS IN ELDERLY, TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A SCOPING REVIEW OF REAL-WORLD EVIDENCE

EHA Library, Jian‑Qing Mi, 4209920

CLINICAL AND EPIDEMIOLOGICAL CHARACTERIZATION OF PATIENTS WITH MULTIPLE MYELOMA IN EL SALVADOR: A REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Karla Fernanda Rodriguez Estrada, 4209921

THERAPEUTIC TRANSITION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: REAL-WORLD ANALYSIS OF INDUCTION OPTIMIZATION IN MEXICAN REFERRAL CENTERS.

EHA Library, Karla Sánchez Hernández, 4209922

SPONTANEOUS RUPTURE OF SPLEEN IN SYSTEMIC LIGHT-CHAIN AMYLOIDOSIS

EHA Library, Yi Xu, 4209923

PROGNOSTIC VALUE OF RED CELL DISTRIBUTION WIDTH IN MULTIPLE MYLOMA: A SINGLE-CENTER EXPERIENCE

EHA Library, Marta Diaz-Lopez, 4209924

SERUM IL-6 AND VEGF AS BIOMARKERS OF TREATMENT RESPONSE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: A PROSPECTIVE OBSERVATIONAL STUDY FROM WESTERN INDIA

EHA Library, Naman Lodha, 4209925

SERUM Β2-MICROGLOBULIN AS AN INDEPENDENT PROGNOSTIC FACTOR IN JAPANESE PATIENTS AGED ≥80 YEARS WITH MULTIPLE MYELOMA

EHA Library, Tsutomu Kobayashi, 4209926

REAL-WORLD OUTCOMES OF SELINEXOR-BASED THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MULTICENTER STUDY FROM TÜRKIYE

EHA Library, Zehra Narlı Özdemir, 4209927

HEMATOLOGY-ONCOLOGISTS’ PERSPECTIVES ON AN ON-BODY INJECTOR FOR ADMINISTRATION OF LARGE-VOLUME SUBCUTANEOUS DRUGS

EHA Library, Carlyn Rose Tan, 4209928

DARATUMUMAB ALONGSIDE CYCLOPHOSPHAMIDE AND DEXAMETHASONE FOR ELDERLY TRANSPLANT-INELIGIBLE MYELOMA

EHA Library, Jiao Lu, 4209929

SURVIVAL IMPROVEMENT IN PRIMARY PLASMA CELL LEUKEMIA: A RETROSPECTIVE ANALYSIS OF NOVEL AGENT-BASED REGIMENS AND STEM CELL TRANSPLANTATION

EHA Library, Hua Bai, 4209930

EFFICACY AND SAFETY OF CARFILZOMIB IN 128 PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: REAL-WORLD EXPERIENCE FROM A SINGLE CENTER

EHA Library, Guezlane Sherifa, 4209931

IMPLICATION OF DIABETES MELLITUS IN THE DEVELOPMENT AND PROGNOSIS OF MULTIPLE MYELOMA: A SINGLE-CENTER EXPERIENCE.

EHA Library, Marta Diaz-Lopez, 4209932

FRONTLINE BORTEZOMIB–MELPHALAN–PREDNISONE IN TRANSPLANT-INELIGIBLE ELDERLY MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTER REAL-WORLD STUDY

EHA Library, Ahlem Slama, 4209933

EXPERIENCE WITH THE DVD REGIMEN IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Ana Felicidad de las Nieves Egea, 4209934

ALTERNATIVE CHEMOMOBILIZATION REGIMENS FOR STEM CELL COLLECTION IN MULTIPLE MYELOMA: REAL-WORLD INDUCTION PRACTICE

EHA Library, Anastasia Semenova, 4209935

MOMENTUM: A PHASE 2, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO EVALUATE THE EFFICACY OF CEMSIDOMIDE + DEXAMETHASONE IN SUBJECTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Binod Dhakal, 4209937

STROMAL PROTECTION OF JAK2V617F-POSITIVE CELLS AGAINST JAK2 INHIBITORS INVOLVES BOTH PARACRINE AND CONTACT-DEPENDENT MECHANISMS

EHA Library, Maya Koren-Michowitz, 4209939

SH2B3 P242S GERMLINE VARIANT ACTIVATES THE JAK2/STAT5 PATHWAY TO MEDIATE ABNORMAL ERYTHROCYTE PROLIFERATION

EHA Library, Yifan Duan, 4209940

AUTOIMMUNE PHENOTYPES AND MUTATIONAL PATTERNS IN MYELOID NEOPLASMS: AGE-DEPENDENT ASSOCIATIONS AND PROGNOSTIC IMPACT OF CLONAL HEMATOPOIESIS.

EHA Library, Sara Galimberti, 4209941

GENOME-WIDE CRISPR-CAS9 SCREENING IDENTIFIES NOVEL MEDIATORS OF RUXOLITINIB RESISTANCE IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Jian Huang, 4209942

ELUCIDATING THE IMPACTS OF TYROSINE KINASE INHIBITORS ON KIT SIGNALLING IN A SYSTEMIC MASTOCYTOSIS CELL LINE

EHA Library, Ben Weekes, 4209943

OPTICAL GENOME MAPPING IN TRIPLE-NEGATIVE ESSENTIAL THROMBOCYTHEMIA

EHA Library, Irene Botella Pérez, 4209944

EXOSOMAL MIR-146A, MIR-155 AND MIR-451A DYNAMICS DURING INTERFERON-ALPHA THERAPY IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Rodolfo Ortiz-Flores, 4209945

THE SOMATIC MUTATIONAL LANDSCAPE OF MYELOFIBROSIS WITH OR WITHOUT CYTOPENIA

EHA Library, Bing Han, 4209946